Today: 29 June 2026
GE Vernova stock price rises as GEV lifts 2026 outlook, but wind delays keep traders wary
30 January 2026
2 mins read

GE Vernova stock price rises as GEV lifts 2026 outlook, but wind delays keep traders wary

New York, Jan 30, 2026, 12:31 ET — Regular session

  • Shares of GE Vernova climbed roughly 1% in midday trading following this week’s upward revision of its 2026 revenue and cash forecasts.
  • The company flagged potential setbacks in wind projects that might weigh on 2026 results, despite steady demand for gas turbines and grid equipment.
  • The next milestone is the deal execution, followed by the first-quarter update set for April 22.

Shares of GE Vernova Inc edged up 0.9% to $723.87 on Friday, after fluctuating between $698.64 and $752.00 earlier in the session. Investors mulled over the company’s updated outlook alongside fresh remarks on its wind division.

This move is significant since GE Vernova occupies a key spot amid a frantic race for power gear—gas turbines, grid tech, and related services—as utilities and data-center builders vie for already scarce supply.

Investors see the stock as a gauge for how long the spike in electricity demand might persist and if manufacturers can boost production without losing pricing power.

GE Vernova’s fourth-quarter update on Wednesday showed $22.2 billion in orders and $11.0 billion in revenue. Adjusted EBITDA — operating profit before interest, tax, depreciation, and amortization — came in at $1.2 billion. Free cash flow reached $1.8 billion, the cash remaining after capital expenditures. The company reported a total backlog of $150 billion and raised its 2026 outlook to $44 billion-$45 billion in revenue and $5.0 billion-$5.5 billion in free cash flow, citing “significant momentum” heading into the year. GE Vernova

GE Vernova plans to finalize its acquisition of Prolec GE early next month, Utility Dive reported, highlighting the transformer maker as key to its long-term strategy. The report noted the company secured 59 gas turbine orders in Q4, a 74% jump from last year. CEO Scott Strazik called the market “growing” and “long-cycle.” Utility Dive also mentioned Strazik’s warning about a tighter deadline for Vineyard Wind, aiming to wrap up by March to avoid losing access to an installation vessel. Utility Dive

A regulatory filing dated Jan. 28 revealed the company’s fourth-quarter results, accompanied by the financial documents as an exhibit.

GE Vernova flagged its wind unit as the key wildcard. This week, the company said installation delays at the Vineyard Wind project off Massachusetts could slash revenue by about $250 million in 2026. If 11 turbines go uninstalled, that hit could deepen to a low double-digit percentage drop in revenue and roughly $400 million in losses. Tariffs that kicked in during Q2 last year also dragged results by around $70 million. On a brighter note, CEO Scott Strazik told analysts the business has secured over $2 billion in electrification orders tied to data centers for 2025. GE Vernova is projecting 2026 revenue to beat Wall Street estimates compiled by LSEG.

GE Vernova’s core turbine and grid businesses go head-to-head with Siemens Energy and Mitsubishi Heavy Industries in gas power, and face off against companies like Vestas in wind. Yet investors have been treating it more as a bet on immediate power shortages than a clean energy stock.

Execution is the next step: shutting down Prolec, scaling up production, and delivering steadier results in wind. The next key event on the calendar is GE Vernova’s Q1 2026 earnings webcast, set for April 22.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • ABBV up 41% in a year; DCF says still cheap after Apogee
    June 29, 2026, 1:50 PM EDT. AbbVie (ABBV) is up 40.9% over the last 12 months, changing hands lately around $253.35. But a DCF model now pegs "fair value" at $434.69 per share-41.7% higher-even after the rally and after the Apogee deal. The model assumes free cash flow jumps to $35.7 billion by 2030. Still, Simply Wall St gives AbbVie just 2 out of 6 on its valuation score, signaling some caution remains. Investors are looking at AbbVie's big pharma weight and new product moves as big factors in the shares from here.
C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers
Previous Story

C3.ai stock price slips in premarket as Automation Anywhere merger-talk report lingers

Texas Instruments stock slips into the weekend after AI-led surge; what TXN watchers track next
Next Story

Texas Instruments stock slips into the weekend after AI-led surge; what TXN watchers track next

Go toTop